|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Share of profits of companies accounted for at equity, net | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Share of profits of companies accounted for at equity, net | |||||
| Depreciation and amortization | |||||
| Changes in value of debentures, net | |||||
| Increase in employee benefit liabilities | |||||
| Loss on disposal of subsidiaries, net of tax (Appendix D) | |||||
| Gain on disposal of discontinued operations, net of tax (Appendix D) | |||||
| Capital gain from Initial public offering of TSG | |||||
| Gain from secondary equity issuance of TSG | |||||
| Loss (gain) from sale of property, plants and equipment | |||||
| Share-based payment expenses | |||||
| and others and deposits, net | |||||
| Net finance expenses (income) related to bank loans and deposits | |||||
| Changes in deferred taxes, net | |||||
| Cash paid in respect of acquisitions of activities | |||||
| Change in liability in respect of business combinations | |||||
| Change in fair value of financial assets measured at fair value through profit or loss | |||||
| Amortization of premium and accrued interest on debt instruments at fair value through other comprehensive income | |||||
| Gain from revaluation of dividend preference derivative in TSG | |||||
| Effect of exchange rate on cash and cash equivalents held in currencies other than the functional currency | |||||
| Working capital adjustments: | |||||
| Decrease (increase) in inventories | |||||
| Decrease (increase) in trade receivables | |||||
| Decrease in other current and long-term accounts receivable | |||||
| Increase in trade payables | |||||
| Increase in other accounts payable and employees and payroll accrual | |||||
| Increase (decrease) in deferred revenues | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Payments for business acquisitions, net of cash acquired (Appendix C) | |||||
| Proceeds from disposal of subsidiary discontinued operation (Appendix D) | |||||
| Proceeds from sale of a subsidiary related to non-controlling interests (Appendix D) | |||||
| Cash paid in conjunction with deferred payments and contingent liabilities related to business combinations | |||||
| Loan extended to related party and others | |||||
| Purchase of intangible assets | |||||
| Purchase of investment measured using the equity method | |||||
| Purchase of other investments | |||||
| Purchase of financial assets measured at fair value through other comprehensive income | |||||
| Purchase of property and equipment | |||||
| Proceeds from maturity and sale of investments in instruments at fair value through other comprehensive income or loss, net | |||||
| Proceeds from sale of property and equipment | |||||
| Dividend from companies accounted for at equity | |||||
| Payment to former shareholders of consolidated company | |||||
| Change in short-term and long-term deposits | |||||
| Capitalization of software development and other costs | |||||
| Loan to an associate company | |||||
| Payment of liability related to the disposal of a subsidiary | |||||
| Deferred payment for acquisition of subsidiaries consolidated in prior periods | |||||
| Net cash provided )used( in investing activities | |||||
| Cash flows from financing activities: | |||||
| Exercise of employees’ stock options in subsidiaries | |||||
| Cash paid in conjunction with acquisitions of activities | |||||
| Dividend paid to non-controlling interests | |||||
| Dividend to Formula’s shareholders | |||||
| Short-term bank credit, net | |||||
| Repayment of long-term loans from banks and others | |||||
| Receipt of long-term loans from banks and others | |||||
| Receipt of short-term loans from banks and others | |||||
| Proceeds from issuance of ordinary shares by subsidiaries | |||||
| Repayment of long-term liabilities to IIA | |||||
| Repayment of debentures | |||||
| Purchase of non-controlling interests | |||||
| Repayment of lease liabilities | |||||
| Cash paid due to exercise of put option by non-controlling interests | |||||
| Payment to non-controlling interests due to put option | |||||
| Net cash used by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| Cash and cash equivalents at the end of the year | |||||
| Interest paid | |||||
| Interest received | |||||
| Taxes paid, net | |||||
| Purchase of property and equipment | |||||
| Intangible assets and goodwill incurred but unpaid at period end | |||||
| Intangible assets and goodwill incurred but unpaid at year end | |||||
| Contingent acquisition consideration | |||||
| Dividend payable to Formula’s shareholders | |||||
| Dividend payable to non-controlling interests | |||||
| Right-of-use asset recognized with corresponding lease liability | |||||
| Working capital (excluding cash and cash equivalents) | |||||
| Inventories | |||||
| Property and equipment | |||||
| Goodwill and intangible assets | |||||
| Right-of-use assets | |||||
| Other long-term assets | |||||
| Liabilities to banks and others | |||||
| Long-term liabilities | |||||
| Lease liabilities | |||||
| Deferred tax liability, net | |||||
| Dividend payable | |||||
| Liability to formerly shareholders | |||||
| Deferred payments and contingent consideration | |||||
| Redeemable non-controlling interests at acquisition date | |||||
| Non-controlling interests at acquisition date | |||||
| Total | |||||
| The subsidiaries’ assets and liabilities at date of sale: | |||||
| Working capital (excluding cash and cash equivalents) | |||||
| Property and equipment | |||||
| Financial assets measured at fair value through profit or loss | |||||
| Goodwill and intangible assets | |||||
| Deferred tax | |||||
| Right-of-use assets | |||||
| Other long-term assets | |||||
| Liabilities to banks and others | |||||
| Long-term liabilities | |||||
| Lease liabilities | |||||
| Deferred tax liability, net | |||||
| Dividend payable | |||||
| Liability in connection with the sale of a subsidiary for consideration in the form of non-controlling interests | |||||
| Capital reserve from transactions with non-controlling interests | |||||
| Reclassification of translation reserve to profit or loss upon disposal | |||||
| Non-controlling interests at acquisition date | |||||
| Redeemable non-controlling interests at acquisition date | |||||
| Gain on disposal and deconsolidation of a subsidiary | |||||
| Subsidiaries assets and liabilities at date of sale | |||||
Loading...